| 1,536 | 27 | 6 |
| 下载次数 | 被引频次 | 阅读次数 |
通过查阅古代本草并且结合近现代文献对陈皮名称源流、品种、道地性、功效主治进行考证,结果发现:历版中国药典均以陈皮为正名具有文献依据;2010版药典将陈皮Citrus reticulata Blanco作为正品收载使用具有一定道理;本草记载的陈皮以广东新会为胜,这与现在陈皮的道地产区相吻合;功效主治与目前基本一致。从古至今对陈皮是否存放;若需存放,存放时间这一问题多有争议。本研究对这一问题提出自己的看法,以期对陈皮的进一步临床应用提供本草依据。
Abstract：The research on the origin of pericarpium citri reticulatae's name,the variety,the geo-herbalism and the effect was done through looking up Chinese ancient agrostology and modern literatures.The results showed that the name of pericarpium citri reticulatae was based on some certain literatures such as China pharmacopoeia.Therefore,it is reasonable that Citrus reticulate Blanco was formally loaded into China pharmacopoeia published in 2010.Material medica had recorded that pericarpium citri reticulatae coming from Xinhui,Guangdong Province was better.So the current genuine producing areas and the effect were the same basically.There are many arguments on whether tangerine peel needs to be kept and how long it was kept all the time.The aim of this study was to expect to provide basis for material medica for the further clinical application of pericarpium citri reticulatae.
[1]国家药典委员会.中国药典(一部)[M].北京:化学工业出版社,2010:176.
[2]国家中医药管理局《中华本草》编委会.中华本草(四部)[M].上海:上海科学技术出版社,1999:886-888.
[3]官福兰,王汝俊,王建华.陈皮及橙皮苷对离体肠管运动的影响[J].时珍国医国药,2002,13(2):65-67.
[4]陈君,郭建生,刘红艳,等.陈皮四大药用部位对豚鼠离体回肠的影响[J].中药药理与临床,2011,27(3):79-81.
[5]郭建生,陈君,聂子文,等.陈皮不同提取物对寒凝气滞胃实寒模型大鼠的影响[J].中成药,2012,34(6):1158-1160.
[6]李庆耀,梁生林,褚洪标等.陈皮促胃肠动力有效部位的筛选研究[J].中成药,2012,34(5):941-943.
[7]沈明勤,叶其正,常复蓉.陈皮水溶性总生物碱的升血压作用量-效关系及药动学研究[J].中国药学杂志,1997,32(2):97-100.
[8]李庆耀,梁生林.陈皮的药用研究进展[J].中成药,2008,30(2):246-248.
[9]Xian-mei Zhou,Yang Zhao,Cui-cui.He Preventive effects of Citrus reticulata essential oil on bleomycin-induced pulmonary fibrosis in rats and the mechanism[J].中西医结合学报,2012,10(2):200-209.
[10]李兰英,彭蕴汝,钱士辉,等.陈皮多甲氧基黄酮类成分对人肝癌SMMC-7721、HepG2细胞株增殖的影响[J].中药材,2007,30(3):324-326.
[11]李兰英,彭蕴汝,钱士辉.陈皮多甲氧基黄酮类成分诱导荷H22肝癌小鼠肿瘤细胞凋亡作用的研究[J].中药材,2009,32(10):1596-1598.
[12]苏明媛,牛江龙,李林,等.川陈皮素的体外抑癌活性及其机制研究[J].中成药,2011,33(9):1479-1483.
[13]Sato T,Koike L,Miyata Y,et al.Inhibition of activator protein-1 binding activity and phosphatidylinositol3-kinase pathway by nobiletin,a polymethoxy flavonoid and suppression of production of matrix metalloproteinases-1 and-9 inhuman fibrosarcoma HT-1080 cells[J].Cancer Res,2002,62:1025-1029.
[14]顾观光.神农本草经[M].哈尔滨:哈尔滨出版社,2007:71-72.
[15]陶弘景.本草经集注[M].昆明:群联出版社,1955:360-362.
[16]王好古.汤液本草[M].上海:中医古籍出版社,2001:156.
[17]汪昂.本草备要[M].北京:中国中医药出版社,1998:187.
[18]苏颂.本草图经(尚志钧辑校)[M].合肥:安徽科学技术出版社出版,1994:496.
[19]李时珍.本草纲目[M].天津:天津古籍出版社,1998:300
[20]张志聪.本草崇原[M].北京:中国中医药出版社,2008:78.
[21]苏颂.本草图经(尚志钧辑校)[M].合肥:安徽科学技术出版社出版,1994:496.
[22]李时珍.本草纲目[M].天津:天津古籍出版社,1998:300.
[23]中华中医药学会.本草逢原[M].北京:华夏出版社,2008:69-70.
[24]陶弘景.名医别录(尚志钧辑校)[M].北京:人民卫生出版社,1986:324.
[25]陈藏器.本草拾遗[M].合肥:安徽科技出版社,2005:381.
[26]甄权.药性论[M].合肥:安徽科学技术出版社,2006:206-207.
[27]日华子本草(尚志钧校辑)[M].合肥:安徽科技出版社,2005:122.
[28]姚澜.本草分经[M].上海:上海科学技术出版社,2001:76-77.
[29]雷斅.雷公炮炙论[M].上海:上海中医学院出版社,1986:52.
[30]刘文泰.本草品汇精要[M].北京:人民卫生出版社,1982:612-613.
[31]李中梓,雷公炮制药性解[M].北京:中国中医药出版社,1998:136-137.
[32]林林,林子夏,莫云燕,等.不同年份新会总黄酮及橙皮苷含量动态分析[J].时珍国医国药,2008,19(6):1432-1433.
[33]易伦朝,谢培山,梁逸曾,等,GC/MS和HPLC对陈皮“陈久者良”的验证[J].中医药学杂志,2005,40(21):1610-1612.
基本信息:
中图分类号:R282.7
引用信息:
[1]魏莹,杨安金,骆利平,等.陈皮本草考证[J].井冈山大学学报(自然科学版),2013,34(04):74-77.
基金信息:
国家中医药管理局中医药行业科研专项(201007011-16)
2013-07-15
2013-07-15